Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Lymphoma, B-Cell

Clinical Trial Details

Overview

Research Study Summary

Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Research Study Title

A Multinational, Multicenter, Open-Label Phase II Study of SyB L-0501 in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Purpose

The purpose of this study is to determine the efficacy of SyB L-0501 in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.

To Learn more
Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Eligibility

Both Male and Female ages 25 Years to 75 Years

Site Locations (18)

Country State City Zip Facility and Contact
Japan Aichi Nagoya Research Site
Japan Ehime Matsuyama Research Site
Japan Fukuoka Kurume Research Site
Japan Gunma Maebashi Research Site
Japan Hokkaido Sapporo Research Site
Japan Ishikawa Kanazawa Research Site
Japan Kanagawa Isehara Research Site
Japan Kumamoto Ninomaru Research Site
Japan Miyagi Sendai Research Site
Japan Okayama Kurashiki Research Site
Japan Okayama Shikata-cho Research Site
Japan Saitama Hidaka Research Site
Japan Shimane Izumo Research Site
Japan Tokyo Chuo-ku Research Site
Japan Akita Research Site
Japan Fukuoka Research Site
Japan Kagoshima Research Site
Japan Kyoto Research Site

Contact

Masahiro Furukawa
81-3-5472-1127

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT01118845

Date Last Changed: May 27, 2010

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.